NCT01705743

Brief Summary

In order to investigate the effect of a combination effect of sevoflurane and nitrous oxide on cerebral electrical activity, the investigators determined the MAC of sevoflurane combined with nitrous oxide inducing isoelectric electroencephalogram (EEG) in 50% of the subjects (MACie) in middle aged subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2012

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 10, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 12, 2012

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2013

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

February 4, 2014

Status Verified

February 1, 2014

Enrollment Period

1 year

First QC Date

October 10, 2012

Last Update Submit

February 3, 2014

Conditions

Keywords

anaesthesiamiddle agedminimal alveolar concentrationsevofluranenitrous oxideisoelectric EEG

Outcome Measures

Primary Outcomes (1)

  • MACie

    Minimal Alveolar Concentration of sevoflurane and NO inducing isoelectric electroencephalogram (EEG) in 50% of the subjects (MACie)

    30min

Study Arms (2)

Group 1 Sevoflurane+Nitrous oxide

ACTIVE COMPARATOR
Drug: Sevoflurane+Nitrous oxide

Group 2 Sevoflurane

ACTIVE COMPARATOR
Drug: Sevoflurane

Interventions

60% nitrous oxide +40% oxygen+ Sevoflurane

Group 1 Sevoflurane+Nitrous oxide

100% oxygen+ Sevoflurane

Group 2 Sevoflurane

Eligibility Criteria

Age45 Years - 64 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • between 45 to 64 years old
  • ASA physical status class 1 or 2
  • elective abdominal surgery
  • Informed Consent

You may not qualify if:

  • history of neurological disease
  • received central nervous system-active drugs
  • cardiac ejection fraction less than 40%
  • history of difficult intubation or anticipated difficult intubation
  • daily alcohol consumption
  • obesity, defined as a body-mass index of more than 30
  • without informed consent
  • others judged inappropriate as subjects for the study by the Study Chair

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430030, China

Location

MeSH Terms

Interventions

Sevoflurane

Intervention Hierarchy (Ancestors)

Methyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbons

Study Officials

  • Yuke Tian, MD.

    Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

October 10, 2012

First Posted

October 12, 2012

Study Start

September 1, 2012

Primary Completion

September 1, 2013

Study Completion

October 1, 2013

Last Updated

February 4, 2014

Record last verified: 2014-02

Locations